vs
维蒙特工业（VMI）与登士柏西诺德（XRAY）财务数据对比。点击上方公司名可切换其他公司
维蒙特工业的季度营收约是登士柏西诺德的1.1倍（$1.0B vs $961.0M），维蒙特工业净利率更高（10.5% vs -15.2%，领先25.7%），维蒙特工业同比增速更快（6.2% vs 6.2%），过去两年登士柏西诺德的营收复合增速更高（0.4% vs -0.5%）
维蒙特工业是美国大型上市制造企业，核心产品包括Valley品牌中心支轴及线性灌溉设备、风电机组支撑结构、照明与交通信号灯杆、钢制公用设施杆塔，在全球农业设备及基建配套领域拥有领先的市场地位和技术优势。
登士柏西诺德是美国牙科设备及耗材制造商，业务覆盖全球120多个国家，在21个国家设有生产工厂。该公司前身为1993年Gendex公司以5.9亿美元收购登士柏国际后整合组建的企业，是全球牙科领域的重要供应商。
VMI vs XRAY — 直观对比
营收规模更大
VMI
是对方的1.1倍
$961.0M
营收增速更快
VMI
高出0.0%
6.2%
净利率更高
VMI
高出25.7%
-15.2%
两年增速更快
XRAY
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $961.0M |
| 净利润 | $108.0M | $-146.0M |
| 毛利率 | 30.8% | 46.1% |
| 营业利润率 | 15.1% | -14.5% |
| 净利率 | 10.5% | -15.2% |
| 营收同比 | 6.2% | 6.2% |
| 净利润同比 | 23.8% | 66.0% |
| 每股收益（稀释后） | $5.51 | $-0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收VMIXRAY
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $961.0M | ||
| Q3 25 | $1.0B | $904.0M | ||
| Q2 25 | $1.1B | $936.0M | ||
| Q1 25 | $969.3M | $879.0M | ||
| Q4 24 | $1.0B | $905.0M | ||
| Q3 24 | $1.0B | $951.0M | ||
| Q2 24 | $1.0B | $984.0M |
净利润VMIXRAY
| Q1 26 | $108.0M | — | ||
| Q4 25 | $168.0M | $-146.0M | ||
| Q3 25 | $99.0M | $-427.0M | ||
| Q2 25 | $-4.0M | $-45.0M | ||
| Q1 25 | $87.3M | $20.0M | ||
| Q4 24 | $77.7M | $-430.0M | ||
| Q3 24 | $83.1M | $-494.0M | ||
| Q2 24 | $99.7M | $-4.0M |
毛利率VMIXRAY
| Q1 26 | 30.8% | — | ||
| Q4 25 | 29.8% | 46.1% | ||
| Q3 25 | 30.4% | 48.8% | ||
| Q2 25 | 30.6% | 52.4% | ||
| Q1 25 | 30.0% | 53.0% | ||
| Q4 24 | 30.2% | 49.3% | ||
| Q3 24 | 29.6% | 52.1% | ||
| Q2 24 | 30.8% | 51.9% |
营业利润率VMIXRAY
| Q1 26 | 15.1% | — | ||
| Q4 25 | 11.2% | -14.5% | ||
| Q3 25 | 13.5% | -24.1% | ||
| Q2 25 | 2.8% | -13.7% | ||
| Q1 25 | 13.2% | 7.2% | ||
| Q4 24 | 11.6% | -56.2% | ||
| Q3 24 | 12.3% | -48.6% | ||
| Q2 24 | 14.2% | 5.1% |
净利率VMIXRAY
| Q1 26 | 10.5% | — | ||
| Q4 25 | 16.2% | -15.2% | ||
| Q3 25 | 9.5% | -47.2% | ||
| Q2 25 | -0.4% | -4.8% | ||
| Q1 25 | 9.0% | 2.3% | ||
| Q4 24 | 7.5% | -47.5% | ||
| Q3 24 | 8.1% | -51.9% | ||
| Q2 24 | 9.6% | -0.4% |
每股收益（稀释后）VMIXRAY
| Q1 26 | $5.51 | — | ||
| Q4 25 | $9.02 | $-0.74 | ||
| Q3 25 | $4.98 | $-2.14 | ||
| Q2 25 | $-1.53 | $-0.22 | ||
| Q1 25 | $4.32 | $0.10 | ||
| Q4 24 | $3.85 | $-2.09 | ||
| Q3 24 | $4.11 | $-2.46 | ||
| Q2 24 | $4.91 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $326.0M |
| 总债务越低越好 | — | $2.3B |
| 股东权益账面价值 | $1.7B | $1.3B |
| 总资产 | $3.4B | $5.4B |
| 负债/权益比越低杠杆越低 | — | 1.70× |
8季度趋势，按日历期对齐
现金及短期投资VMIXRAY
| Q1 26 | $160.2M | — | ||
| Q4 25 | $187.1M | $326.0M | ||
| Q3 25 | $226.1M | $363.0M | ||
| Q2 25 | $208.5M | $359.0M | ||
| Q1 25 | $184.4M | $398.0M | ||
| Q4 24 | $164.3M | $272.0M | ||
| Q3 24 | $200.5M | $296.0M | ||
| Q2 24 | $163.1M | $279.0M |
总债务VMIXRAY
| Q1 26 | — | — | ||
| Q4 25 | $795.7M | $2.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $730.6M | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益VMIXRAY
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.5B | $2.0B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.5B | $1.9B | ||
| Q3 24 | $1.5B | $2.5B | ||
| Q2 24 | $1.5B | $3.1B |
总资产VMIXRAY
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $5.4B | ||
| Q3 25 | $3.4B | $5.7B | ||
| Q2 25 | $3.3B | $6.1B | ||
| Q1 25 | $3.4B | $6.0B | ||
| Q4 24 | $3.3B | $5.8B | ||
| Q3 24 | $3.5B | $6.6B | ||
| Q2 24 | $3.5B | $6.9B |
负债/权益比VMIXRAY
| Q1 26 | — | — | ||
| Q4 25 | 0.49× | 1.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.47× | 0.90× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $101.0M |
| 自由现金流经营现金流 - 资本支出 | — | $60.0M |
| 自由现金流率自由现金流/营收 | — | 6.2% |
| 资本支出强度资本支出/营收 | — | 4.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $104.0M |
8季度趋势，按日历期对齐
经营现金流VMIXRAY
| Q1 26 | — | — | ||
| Q4 25 | $111.2M | $101.0M | ||
| Q3 25 | $112.5M | $79.0M | ||
| Q2 25 | $167.6M | $48.0M | ||
| Q1 25 | $65.1M | $7.0M | ||
| Q4 24 | $193.4M | $87.0M | ||
| Q3 24 | $225.1M | $141.0M | ||
| Q2 24 | $130.8M | $208.0M |
自由现金流VMIXRAY
| Q1 26 | — | — | ||
| Q4 25 | $70.4M | $60.0M | ||
| Q3 25 | $70.6M | $40.0M | ||
| Q2 25 | $135.6M | $16.0M | ||
| Q1 25 | $34.8M | $-12.0M | ||
| Q4 24 | $167.8M | $36.0M | ||
| Q3 24 | $204.6M | $98.0M | ||
| Q2 24 | $112.5M | $156.0M |
自由现金流率VMIXRAY
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 6.2% | ||
| Q3 25 | 6.7% | 4.4% | ||
| Q2 25 | 12.9% | 1.7% | ||
| Q1 25 | 3.6% | -1.4% | ||
| Q4 24 | 16.2% | 4.0% | ||
| Q3 24 | 20.1% | 10.3% | ||
| Q2 24 | 10.8% | 15.9% |
资本支出强度VMIXRAY
| Q1 26 | — | — | ||
| Q4 25 | 3.9% | 4.3% | ||
| Q3 25 | 4.0% | 4.3% | ||
| Q2 25 | 3.0% | 3.4% | ||
| Q1 25 | 3.1% | 2.2% | ||
| Q4 24 | 2.5% | 5.6% | ||
| Q3 24 | 2.0% | 4.5% | ||
| Q2 24 | 1.8% | 5.3% |
现金转化率VMIXRAY
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 1.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | 0.35× | ||
| Q4 24 | 2.49× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | 1.31× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
VMI
| Infrastructure | $803.2M | 78% |
| Agriculture | $226.0M | 22% |
XRAY
| Essential Dental Solutions | $372.0M | 39% |
| Equipment And Instruments | $160.0M | 17% |
| Implants And Prosthetics | $150.0M | 16% |
| CADCAM | $139.0M | 14% |
| Wellspect Healthcare | $88.0M | 9% |
| Orthodontics | $52.0M | 5% |
